JP Patent

JP5784623B2 — 速放性錠剤製剤

Assigned to AstraZeneca UK Ltd · Expires 2015-09-24 · 11y expired

What this patent protects

Patent listed against Tradjenta.

Drugs covered by this patent

Tradjenta (LINAGLIPTIN) · Boehringer Ingelheim

Patent Metadata

Patent number: JP5784623B2
Jurisdiction: JP
Classification: —
Expires: 2015-09-24
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca UK Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.